FDA clears Viz.ai algorithm for intracerebral hemmorhage
Viz.ai announced that it received FDA 510(k) clearance for its Viz ICH Plus algorithm for providing volume measurements of brain bleeds.
Stay updated with breaking news from Jayme Strauss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Viz.ai announced that it received FDA 510(k) clearance for its Viz ICH Plus algorithm for providing volume measurements of brain bleeds.
SAN FRANCISCO--(BUSINESS WIRE)--Feb 8, 2024--
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its algorithm, Viz ICH Plus, intended to automate the process of...
SAN FRANCISCO--(BUSINESS WIRE)--Feb 8, 2024--
These first “SAMDs” leverage ECGs to pick up worsening EF and hypertrophic cardiomyopathy, but more loom on the horizon.